Isomorphic Labs · Series B
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Amount
$2.1B
Round
Series B
Valuation
—
Announced
May 2026
Investors
Lead investor
Participating investors
Notes
funding refresh
Other Isomorphic Labs rounds
| Date | Round | Amount | |
|---|---|---|---|
| — | Series A | $600M | Details → |